Feb. 19, 2004 — Adjuvant treatment with autologous renal tumor cell vaccine seems to be beneficial in patients with organ-confined renal cell carcinoma, according to the results of a phase III, ...
The presence and number of kidney cysts, particularly in the medulla, may be an additional imaging-based biomarker for progressive CKD after radical nephrectomy for kidney cancer. Among patients who ...
Part B of the Checkmate 914 trial showed no disease-free survival (DFS) benefit with adjuvant nivolumab monotherapy in patients with localized renal cell carcinoma (RCC) at high risk of recurrence ...
Nephrectomy after HIF-2α antagonist therapy is feasible and safe. Renal surgery following or during exposure to a HIF-2α antagonist appears safe and feasible, with perioperative transfusion rates and ...
Kidney removal, medically known as a nephrectomy, is a major surgical procedure performed to treat kidney disease, cancer, or to enable a healthy individual to donate a kidney. While the operation can ...
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor ...
Please provide your email address to receive an email when new articles are posted on . Overall, 47 donors in the study developed sustained low eGFR or moderate-severe albuminuria. Median time for the ...
SAN FRANCISCO -- The use of adjuvant pembrolizumab (Keytruda) boosted overall survival (OS) in post-surgical patients with clear cell renal cell carcinoma (RCC) at risk for recurrence, according to ...
The researchers found that preoperative hypertension, dialysis, and steroid use were most common. HealthDay News – Major complications occur in 7.0% of patients undergoing nephrectomy with a diagnosis ...